EcoDrugPlus

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSBTAG00000000438
Gene Symbol: GNRHR
7 Enzyme and pathways 5 Cross references
242 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSBTAG00000047599
Gene Symbol: GHRHR
7 Enzyme and pathways 5 Cross references
205 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSBTAG00000010874
Gene Symbol: GHSR
4 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSBTAG00000014576
Gene Symbol: GUCY1A1
2 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSBTAG00000044144
Gene Symbol: GUCY1A2
2 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSBTAG00000003840
Gene Symbol: GUCY1B1
2 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSBTAG00000018103
Gene Symbol: HMGB1
34 Enzyme and pathways 5 Cross references
264 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSBTAG00000044071
Gene Symbol: HRH2
8 Enzyme and pathways 5 Cross references
261 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSBTAG00000031625
Gene Symbol: HRH3
6 Enzyme and pathways 5 Cross references
127 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSBTAG00000020467
Gene Symbol: HRH4
8 Enzyme and pathways 5 Cross references
116 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSBTAG00000012698
Gene Symbol: HDAC1
47 Enzyme and pathways 5 Cross references
293 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSBTAG00000011000
Gene Symbol: HDAC10
7 Enzyme and pathways 5 Cross references
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).